002898.SZ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 10:04):

Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China...

Stats
Dzisiejszy wolumen	3.13M
Średni wolumen	8.51M
Kapitalizacja rynkowa	1.71B
EPS	CNY0.00760 ( 2023-09-30 )
Następna data zysków	( CNY0 ) 2024-05-16
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	193.80
ATR14	CNY0.00900 (0.09%)

Wolumen Korelacja

Długi: -0.05 (neutral)

Krótki: 0.54 (weak)

Signal:(46.659) Neutral

Sailong Pharmaceutical Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sailong Pharmaceutical Korelacja - Waluta/Towar

-0.30
( neutral )

-0.35
( neutral )

0.00
( neutral )

0.22
( neutral )

Sailong Pharmaceutical Finanse

Annual	2023
Przychody:	CNY310.63M
Zysk brutto:	CNY143.47M (46.19 %)
EPS:	CNY0.0542

FY	2023
Przychody:	CNY310.63M
Zysk brutto:	CNY143.47M (46.19 %)
EPS:	CNY0.0542

FY	2022
Przychody:	CNY264.19M
Zysk brutto:	CNY141.25M (53.47 %)
EPS:	CNY-0.210

FY	2021
Przychody:	CNY247.08M
Zysk brutto:	CNY163.61M (66.22 %)
EPS:	CNY-0.133

Financial Reports:

No articles found.

Sailong Pharmaceutical

Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, gaicycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, and pantoprazole sodium products. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, proton pump inhibitors, anti-infectives, anti-bleeding medicine, analgesics, and other fields. The company was formerly known as Zhuhai Sailong Pharmaceutical Co.,Ltd. and changed its name to Sailong Pharmaceutical Group Co., Ltd. in September 2021. Sailong Pharmaceutical Group Co., Ltd. was founded in 2002 and is based in Zhuhai, China.